Skip to main content
logo
Nykode Therapeutics AS (VACBF)
OTCMKTS · Delayed Price · Currency is USD
0.3800
0.00 (0.00%)
At close: Feb 10, 2026

Nykode Therapeutics AS Revenue

Nykode Therapeutics AS had revenue of $118.00K in the quarter ending September 30, 2025, a decrease of -82.26%. This brings the company's revenue in the last twelve months to $7.35M, up 68.10% year-over-year. In the year 2024, Nykode Therapeutics AS had annual revenue of $9.16M, down -31.26%.

Revenue (ttm)
7.35M
Revenue Growth
+68.10%
P/S Ratio
18.11
Revenue / Employee
118.48K
Employees
62
Market Cap
133.03M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.16M-4.17M-31.26%
Dec 31, 202313.32M4.29M47.56%
Dec 31, 20229.03M-26.74M-74.76%
Dec 31, 202135.77M-179.93M-83.42%
Dec 31, 2020215.70M214.28M15,175.85%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioStem Technologies292.21M
Vaxart148.20M
Silence Therapeutics25.83M
Nuo Therapeutics2.61M
Northwest Biotherapeutics937.00K
Arch Biopartners198.11K
Revenue Rankings

Nykode Therapeutics AS News

More News